Ramie Tritt, MD
Otolaryngology · Atlanta, GANPI 1700881760
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,115 of the $3,713 with a category attached, or 83.9%. 17 manufacturers reported payments, led by Aerin Medical Inc. at 27.8% of the total.
Across 119 payments — averaging $31.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$1K
- Regeneron Healthcare Solutions, Inc.$776
- Stryker$490
- Optinose US, Inc.$442
- Sanofi$337
- GSK$189
- plus $448 from 11 others
Across 1 payment — averaging $636,526 each. An ownership or investment interest held by the physician or an immediate family member.
- Stimlabs LLC$637K
What the payments were for
- Speaking & faculty fees$50013%
- Food & beverage$3,11584%
- Education$983%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 10 | $1,031 |
| Regeneron Healthcare Solutions, Inc. | 26 | $776 |
| Stryker | 13 | $490 |
| Optinose US, Inc. | 22 | $442 |
| Sanofi | 14 | $337 |
| GSK | 11 | $189 |
| Novartis | 8 | $154 |
| Alk-abello, Inc | 4 | $59 |
| Intersect ENT, Inc. | 2 | $43 |
| Merck | 2 | $39 |
| Grifols USA, LLC | 1 | $25 |
| CSL Behring | 1 | $25 |
| Neurent Medical Limited | 1 | $25 |
| Amgen | 1 | $24 |
| Shire North American Group Inc | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| AbbVie | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,713 in reported general payments places this provider in the 80th percentile of 308 otolaryngology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 18 | $69,635 |
| Azelastine Hcl | 256 | $9,212 |
| Fluticasone Propionate | 289 | $5,254 |
| Ipratropium Bromide | 80 | $3,474 |
| Fluconazole | 22 | $770 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 58 | $736 |
| Doxycycline Hyclate | 23 | $442 |
| Pantoprazole Sodium | 28 | $333 |
| Montelukast Sodium | 42 | $302 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 45 | $286 |
| Famotidine | 22 | $149 |
| Methylprednisolone | 23 | $135 |
| Omeprazole | 13 | $91 |
| Ciprofloxacin Hcl | 11 | $63 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Atlanta
- Karen HoffmannAtlanta$223K
- Jose StolovitzkyAtlanta$81K
- Daniel CarothersAtlanta$8K
- Adam KleinAtlanta$8K
- Pradeep SinhaAtlanta$7K
- Kingsley ChinAtlanta$6K
- John SongAtlanta$6K
- James HamiltonAtlanta$5K
- Elizabeth ShawAtlanta$5K
- Michael KoriwchakAtlanta$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.